Our Impact

Funding Breakdown 2015 – 2025

2015

• $3,000 to the Pediatric Leukemia Research Fund
• $3,000 to the Leukemia Research Fund
• $4,449 to the Bone Marrow Transplant Service Fund

2016

• $10,000 to support a fellow in the Bone Marrow Transplant Service
• $7,615 to the Leukemia Research Fund

2017

• $11,820.50 to support Dr. Michael Khara’s study on acute myeloid leukemia
• $11,820.50 to support Dr. Guenther Koehne’s study on hematologic malignancies and disorders

2018

• $12,612.50 to support Epigenetics research
• $12,612.50 to support Car-T Cell immunotherapy clinical trials

2019

• $10,000 to support Pediatric Fast Track under the direction of Dr. Andrew Kung
• $10,000 to support Dr. Jae Park’s leukemia research
• $7,493 to support Dr. Kristian Helin’s epigenetics research

2020

• $13,136.50 to support Dr. Joan Massagué’s metastasis research

2021

• $14,000 to support Dr. Andrew Intlekofer’s IDH-Mutated Acute Myeloid Leukemia research

2022

• $7,000 to support Microbiome and Cancer Initiative at MSK, led by Marcel van den Brink, MD, PhD, Head of the Division of Hematologic Malignancies

2023

• $6,735 to support Dr. Jae Park’s Hairy cell leukemia research (HCL)
• $6,735 to support Dr. Omar Abdel-Wahab’s histiocytosis research

2024

• $10,350 to support Dr. Jae Park’s AML clinical trial

2025

• $12,855 to support Dr. Maria Cancio’s work with coord blood transplantation for AML
• $12,855 to support Dr. Raajit Rampal’s use of targeted therapies for Myelofibrosis treatment